Medtronic Cardiovascular — Goodwill increased by 0.1% to $8.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.4%, from $7.93B to $8.04B. Over 3 years (FY 2022 to FY 2025), Cardiovascular — Goodwill shows relatively stable performance with a 3.0% CAGR.
A significant increase suggests active M&A activity, while a decrease may signal impairment charges due to underperforming acquisitions.
This represents the intangible asset value recorded when the company acquires other businesses or technologies within th...
Comparable to goodwill balances in the medical device segments of companies that grow through frequent acquisitions.
mdt_segment_cardiovascular_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.21B | $7.22B | $7.26B | $7.23B | $7.16B | $7.17B | $7.78B | $7.87B | $7.87B | $7.88B | $7.85B | $7.91B | $7.97B | $7.98B | $7.97B | $7.93B | $8.02B | $8.05B | $8.03B | $8.04B |
| QoQ Change | — | +0.1% | +0.6% | -0.4% | -1.0% | +0.1% | +8.6% | +1.2% | -0.0% | +0.1% | -0.4% | +0.7% | +0.8% | +0.1% | -0.1% | -0.5% | +1.1% | +0.3% | -0.2% | +0.1% |
| YoY Change | — | — | — | — | -0.7% | -0.7% | +7.2% | +8.9% | +10.0% | +10.0% | +0.8% | +0.4% | +1.2% | +1.2% | +1.5% | +0.3% | +0.6% | +0.9% | +0.7% | +1.4% |